Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04133350 · ClinicalTrials.gov registry record · NA
Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)
A NA study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04133350 is a NA study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 2 participants.
The verdict
NCT04133350, a NA study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a prospective, single-arm, unblinded pilot study and registry that aims to demonstrate adherence to adaptive servo-ventilation (ASV) therapy in patients with moderate to severe sleep disordered breathing who have been recently hospitalized. ASV therapy has been linked to improved outcomes in this population, but adherence to therapy is low. The AirCurve 10 ASV device that will be used for this study employs newer technologies, such as web-based monitoring and provides patients feedback, which may increase therapy adherence and therefore improve patient outcomes.
Interventions
- BEHAVIORAL Active Patient Engagement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2021-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04133350
The ClinicalTrials.gov registry entry for NCT04133350 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Active Patient Engagement is the first listed.
NCT04133350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04133350 about?
NCT04133350 is a clinical study titled "Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)". This is a prospective, single-arm, unblinded pilot study and registry that aims to demonstrate adherence to adaptive servo-ventilation (ASV) therapy in patients with moderate to severe sleep disordered breathing who have been recently hospitalized. ASV therapy has been linked to improved outcomes in...
What is the current status of trial NCT04133350?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-10-16. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT04133350?
The interventions under investigation include: Active Patient Engagement (BEHAVIORAL).
Who is sponsoring clinical trial NCT04133350?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.